VISTAGEN THERAPEUTICS INC (VTGN) Institutional Shareholders
VISTAGEN THERAPEUTICS INC (VTGN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.54M in VTGN holdings during the latest filing period.
Commodore Capital Lp is currently the largest disclosed institutional shareholder of VTGN tracked by InsiderSet, reporting ownership valued at approximately $630,228 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $669,268.8, representing an estimated gain of +6.19% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 78% of the total disclosed VTGN value among the investors covered in this analysis. Major shareholders include Commodore Capital Lp, Vanguard Capital Management Llc, Two Sigma Investments, Lp, and several other long-term asset managers with concentrated positions in VISTAGEN THERAPEUTICS INC (VTGN).
This page ranks the largest institutional VTGN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
46
Total Reported Value
$2.54M
Largest Holder
Commodore Capital Lp
Largest Position
$630,228
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
77
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Commodore Capital Lp | 0.04% | 2,788,620 | $630,228 | $669,269 | +$39,041 | +6.19% | |
| Vanguard Capital Management Llc | 0.00% | 1,574,200 | $355,769 | $377,808 | +$22,039 | +6.19% | |
| Two Sigma Investments, Lp | 0.00% | 847,992 | $191,646 | $203,518 | +$11,872 | +6.19% | |
| Acadian Asset Management Llc | 0.00% | 794,579 | $178,000 | $190,699 | +$12,699 | +7.13% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 730,500 | $165,093 | $175,320 | +$10,227 | +6.19% |
| Ikarian Capital, Llc | 0.02% | 519,077 | $117,311 | $124,578 | +$7,267 | +6.20% | |
| Advisorshares Investments Llc | 0.01% | 438,643 | $99,133 | $105,274 | +$6,141 | +6.20% | |
| Luminus Management Llc | 0.06% | 403,115 | $91,104 | $96,748 | +$5,644 | +6.19% | |
| Geode Capital Management, Llc | 0.00% | 365,002 | $82,514 | $87,600 | +$5,086 | +6.16% | |
| Adar1 Capital Management, Llc | 0.00% | 351,141 | $79,358 | $84,274 | +$4,916 | +6.19% | |
| Blackrock, Inc. | 0.00% | 345,432 | $78,068 | $82,904 | +$4,836 | +6.19% | |
| Group One Trading Llc | 0.00% | 304,385 | $68,791 | $73,052 | +$4,261 | +6.19% | |
| Verdad Advisers, Lp | 0.06% | 293,343 | $66,296 | $70,402 | +$4,106 | +6.19% | |
| Vanguard Fiduciary Trust Co | 0.00% | 217,700 | $49,200 | $52,248 | +$3,048 | +6.20% | |
| Jane Street Group, Llc | 0.00% | 164,827 | $37,251 | $39,558 | +$2,307 | +6.19% | |
| Boothbay Fund Management, Llc | 0.00% | 134,571 | $30,413 | $32,297 | +$1,884 | +6.19% | |
| State Street Corp | 0.00% | 121,114 | $27,372 | $29,067 | +$1,695 | +6.19% | |
| Xtx Topco Ltd | 0.00% | 118,380 | $26,754 | $28,411 | +$1,657 | +6.19% | |
| Northern Trust Corp | 0.00% | 80,823 | $18,266 | $19,398 | +$1,132 | +6.19% | |
| Stempoint Capital Lp | 0.00% | 616,749 | $17,276 | $148,020 | +$130,744 | +756.79% | |
| Citadel Advisors Llc | 0.00% | 68,839 | $15,558 | $16,521 | +$963 | +6.19% | |
| Virtu Financial Llc | 0.00% | 66,021 | $15,000 | $15,845 | +$845 | +5.63% | |
| Ubs Group Ag | 0.00% | 57,830 | $13,070 | $13,879 | +$809 | +6.19% | |
| Gsa Capital Partners Llp | 0.00% | 54,584 | $12,000 | $13,100 | +$1,100 | +9.17% | |
| Osaic Holdings, Inc. | 0.00% | 43,888 | $10,076 | $10,533 | +$457 | +4.54% | |
| Confluence Wealth Services, Inc. | 0.00% | 32,610 | $7,370 | $7,826 | +$456 | +6.19% | |
| Scientech Research Llc | 0.01% | 30,283 | $6,844 | $7,268 | +$424 | +6.19% | |
| Stonex Group Inc. | 0.00% | 10,840 | $6,621 | $2,602 | -$4,019 | -60.71% | |
| R Squared Ltd | 0.00% | 27,745 | $6,270 | $6,659 | +$389 | +6.20% | |
| Kestra Advisory Services, Llc | 0.00% | 26,000 | $5,876 | $6,240 | +$364 | +6.19% | |
| Tower Research Capital Llc (Trc) | 0.00% | 18,136 | $4,099 | $4,353 | +$254 | +6.19% | |
| Bank Of America Corp | 0.00% | 16,570 | $3,745 | $3,977 | +$232 | +6.19% | |
| Truvestments Capital Llc | 0.00% | 15,540 | $3,512 | $3,730 | +$218 | +6.20% | |
| Farther Finance Advisors, Llc | 0.00% | 15,000 | $3,390 | $3,600 | +$210 | +6.19% | |
| Raymond James Financial Inc | 0.00% | 14,851 | $3,356 | $3,564 | +$208 | +6.21% | |
| Simplex Trading, Llc | 0.00% | 14,295 | $3,230 | $3,431 | +$201 | +6.22% | |
| Deutsche Bank Ag\ | 0.00% | 12,000 | $2,760 | $2,880 | +$120 | +4.35% | |
| Vanguard Global Advisers, Llc | 0.00% | 10,809 | $2,443 | $2,594 | +$151 | +6.19% | |
| Performa Ltd (Us), Llc | 0.00% | 5,500 | $1,243 | $1,320 | +$77 | +6.19% | |
| Citigroup Inc | 0.00% | 3,822 | $864 | $917 | +$53 | +6.17% | |
| Cwm, Llc | 0.00% | 582 | $333 | $140 | -$193 | -58.05% | |
| Jones Financial Companies Lllp | 0.00% | 114 | $80 | $27 | -$53 | -65.80% | |
| Morgan Stanley | 0.00% | 298 | $67 | $72 | +$5 | +6.75% | |
| Sbi Securities Co., Ltd. | 0.00% | 289 | $65 | $69 | +$4 | +6.71% | |
| Jpmorgan Chase & Co | 0.00% | 82 | $62 | $20 | -$42 | -68.26% | |
| Bnp Paribas Financial Markets | 0.00% | 6 | $1 | $1 | +$0 | +44.00% |
Frequently asked questions about VTGN
Who owns the most VTGN stock?
The largest holders of VTGN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VISTAGEN THERAPEUTICS INC (VTGN).
Is VTGN widely held by superinvestors?
Many widely followed stocks like VTGN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VTGN is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.